13F portfolio / Long/short equity
Glenview Capital
Larry Robbins (founder)
Glenview Capital Management is a New York hedge fund founded by Larry Robbins in 2000.
- Reported 13F value
- $5.0B
- Positions
- 42
- Est. 1-yearEstimate
- +40.0%SPY +15.7%
- Est. 3-year, annualizedEstimate
- +31.7%SPY +22.8%
As of Jun 30, 2026 · filed Aug 14, 2026
Holdings
12 new · 13 added · 14 trimmed · 3 unchanged · 11 sold out
| 1 | GPN on Yahoo Finance (opens in a new tab) | Global Pmts IncCOM | 12.9% | $646M | 8,906,709 | Added +40.0% | $90.56* | $82.88 | -8.5% |
| 2 | CVS on Yahoo Finance (opens in a new tab) | CVS Health CorpCOM | 10.0% | $499M | 4,824,799 | Trimmed -41.1% | $57.80 | $92.25 | +59.6% |
| 3 | THC on Yahoo Finance (opens in a new tab) | Tenet Healthcare CorpCOM NEW | 8.4% | $418M | 2,235,666 | Added +46.6% | $115.92* | $267.14 | +130.5% |
| 4 | TMO on Yahoo Finance (opens in a new tab) | Thermo Fisher Scientific IncCOM | 6.3% | $314M | 627,240 | Added +150.4% | $470.27 | $686.14 | +45.9% |
| 5 | AMZN on Yahoo Finance (opens in a new tab) | Amazon Com IncCOM | 6.1% | $303M | 1,271,687 | Added +20.1% | $212.35* | $249.20 | +17.4% |
| 6 | A on Yahoo Finance (opens in a new tab) | Agilent Technologies IncCOM | 5.2% | $262M | 1,969,541 | New | $121.44 | $172.32 | +41.9% |
| 7 | DHR on Yahoo Finance (opens in a new tab) | Danaher Corp DelCOM | 4.4% | $218M | 1,145,979 | Added +633.3% | $182.97 | $229.01 | +25.2% |
| 8 | META on Yahoo Finance (opens in a new tab) | Meta Platforms IncCL A | 4.0% | $201M | 356,841 | Added +190.9% | $619.97 | $706.95 | +14.0% |
| 9 | AMD on Yahoo Finance (opens in a new tab) | Advanced Micro Devices IncCOM | 3.5% | $173M | 298,410 | Trimmed -54.1% | $220.23 | $534.28 | +142.6% |
| 10 | TEVA on Yahoo Finance (opens in a new tab) | Teva Pharmaceutical Inds LtdSPONSORED ADS | 3.4% | $172M | 5,081,091 | Trimmed -23.7% | $15.06 | $41.03 | +172.5% |
| 11 | VTRS on Yahoo Finance (opens in a new tab) | Viatris IncCOM | 3.1% | $157M | 9,877,409 | Added +8.7% | $10.19 | $18.32 | +79.8% |
| 12 | UBER on Yahoo Finance (opens in a new tab) | Uber Technologies IncCOM | 2.6% | $129M | 1,793,598 | Added +23.2% | $76.43* | $69.99 | -8.4% |
| 13 | CNC on Yahoo Finance (opens in a new tab) | Centene Corp DelCOM | 2.4% | $121M | 1,886,055 | Trimmed -41.3% | $38.11 | $69.22 | +81.7% |
| 14 | BFLY on Yahoo Finance (opens in a new tab) | Butterfly Network IncCOM CL A | 2.4% | $121M | 14,335,055 | Unchanged | $1.85* | $7.32 | +294.7% |
| 15 | CI on Yahoo Finance (opens in a new tab) | The Cigna GroupCOM | 2.3% | $114M | 412,223 | Trimmed -17.4% | $272.30* | $300.23 | +10.3% |
| 16 | HUM on Yahoo Finance (opens in a new tab) | Humana IncCOM | 2.0% | $101M | 254,216 | Trimmed -24.1% | $203.49 | $417.60 | +105.2% |
| 17 | XYZ on Yahoo Finance (opens in a new tab) | Block IncCL A | 1.8% | $91M | 1,197,046 | Trimmed -12.3% | $67.29 | $77.54 | +15.2% |
| 18 | DKS on Yahoo Finance (opens in a new tab) | Dicks Sporting Goods IncCOM | 1.8% | $91M | 401,067 | Added +34.2% | $193.23 | $144.10 | -25.4% |
| 19 | GENI on Yahoo Finance (opens in a new tab) | Genius Sports LimitedSHARES CL A | 1.6% | $82M | 13,495,287 | Added +57.6% | $6.98 | $6.41 | -8.2% |
| 20 | ONTO on Yahoo Finance (opens in a new tab) | Onto Innovation IncCOM | 1.6% | $78M | 205,791 | Trimmed -31.3% | $119.19 | $224.38 | +88.2% |
| 21 | LLY on Yahoo Finance (opens in a new tab) | Eli Lilly & CoCOM | 1.4% | $69M | 57,771 | New | $1019.47 | $1257.49 | +23.3% |
| 22 | UAL on Yahoo Finance (opens in a new tab) | United Airls Hldgs IncCOM | 1.3% | $67M | 494,736 | Unchanged | $85.64 | $96.99 | +13.2% |
| 23 | EYE on Yahoo Finance (opens in a new tab) | National Vision Hldgs IncCOM | 1.2% | $59M | 3,101,083 | Added +98.0% | $20.68 | $17.35 | -16.1% |
| 24 | CSCO on Yahoo Finance (opens in a new tab) | Cisco Sys IncCOM | 1.0% | $49M | 413,332 | Added +21.6% | $81.98 | $107.49 | +31.1% |
| 25 | ESI on Yahoo Finance (opens in a new tab) | Element Solutions IncCOM | 0.9% | $47M | 994,579 | Trimmed -38.9% | $22.12* | $34.96 | +58.0% |
| 26 | AMAT on Yahoo Finance (opens in a new tab) | Applied Matls IncCOM | 0.9% | $47M | 65,201 | Trimmed -66.9% | $271.78 | $416.19 | +53.1% |
| 27 | MKSI on Yahoo Finance (opens in a new tab) | Mks Inc.COM | 0.9% | $44M | 98,532 | New | $312.48 | $218.50 | -30.1% |
| 28 | FUN on Yahoo Finance (opens in a new tab) | Six Flags Entertainment CorpCOM | 0.9% | $43M | 2,017,821 | Trimmed -9.2% | $17.48 | $8.20 | -53.1% |
| 29 | STM on Yahoo Finance (opens in a new tab) | Stmicroelectronics N VNY REGISTRY | 0.8% | $42M | 560,060 | New | $59.97 | $45.62 | -23.9% |
| 30 | ABBV on Yahoo Finance (opens in a new tab) | Abbvie IncCOM | 0.7% | $37M | 148,913 | New | $212.07 | $284.98 | +34.4% |
| 31 | AZN on Yahoo Finance (opens in a new tab) | Astrazeneca PLCORD | 0.7% | $35M | 184,279 | New | $188.09 | $164.87 | -12.3% |
| 32 | BLCO on Yahoo Finance (opens in a new tab) | Bausch Plus Lomb CorpCOMMON SHARES | 0.6% | $32M | 1,918,148 | Unchanged | $14.06 | $16.31 | +16.0% |
| 33 | BKR on Yahoo Finance (opens in a new tab) | Baker Hughes CompanyCL A | 0.5% | $27M | 493,519 | Added +62.5% | $59.46 | $55.75 | -6.2% |
| 34 | ELV on Yahoo Finance (opens in a new tab) | Elevance Health Inc FormerlyCOM | 0.5% | $26M | 66,599 | New | $368.11 | $428.93 | +16.5% |
| 35 | MCHP on Yahoo Finance (opens in a new tab) | Microchip Technology Inc.COM | 0.5% | $24M | 265,577 | New | $88.40 | $73.87 | -16.4% |
| 36 | BRKR on Yahoo Finance (opens in a new tab) | Bruker CorpCOM | 0.3% | $15M | 252,169 | New | $46.60 | $54.72 | +17.4% |
| 37 | NVS on Yahoo Finance (opens in a new tab) | Novartis AGSPONSORED ADR | 0.3% | $14M | 86,909 | New | $149.91 | $150.88 | +0.6% |
| 38 | DOCN on Yahoo Finance (opens in a new tab) | Digitalocean Hldgs IncCOM | 0.3% | $13M | 84,812 | Trimmed -66.1% | $44.03 | $96.89 | +120.0% |
| 39 | PRMB on Yahoo Finance (opens in a new tab) | Primo Brands CorporationCLASS A COM SHS | 0.2% | $10M | 404,971 | Trimmed -23.7% | $19.05 | $19.44 | +2.1% |
| 40 | BSX on Yahoo Finance (opens in a new tab) | Boston Scientific CorpCOM | 0.1% | $5M | 113,096 | New | $54.30 | $44.06 | -18.8% |
| 41 | CAH on Yahoo Finance (opens in a new tab) | Cardinal Health IncCOM | 0.1% | $4M | 18,018 | New | $206.88 | $252.31 | +22.0% |
| 42 | TECH on Yahoo Finance (opens in a new tab) | Bio-Techne CorpCOM | 0.1% | $4M | 58,324 | Trimmed -68.7% | $56.09 | $72.49 | +29.2% |
Sold out since Q1 2026
- DXC on Yahoo Finance (opens in a new tab)DXC Technology Co$112M at Q1 2026
- GTM on Yahoo Finance (opens in a new tab)Zoominfo Technologies Inc$95M at Q1 2026
- USFD on Yahoo Finance (opens in a new tab)US Foods Hldg Corp$35M at Q1 2026
- Z on Yahoo Finance (opens in a new tab)Zillow Group Inc$33M at Q1 2026
- LAD on Yahoo Finance (opens in a new tab)Lithia Mtrs Inc$32M at Q1 2026
- LION on Yahoo Finance (opens in a new tab)Lionsgate Studios Corp$27M at Q1 2026
- MYGN on Yahoo Finance (opens in a new tab)Myriad Genetics Inc$24M at Q1 2026
- SGRY on Yahoo Finance (opens in a new tab)Surgery Partners Inc$21M at Q1 2026
- AKAM on Yahoo Finance (opens in a new tab)Akamai Technologies Inc$18M at Q1 2026
- INTC on Yahoo Finance (opens in a new tab)Intel Corp$18M at Q1 2026
- BIIB on Yahoo Finance (opens in a new tab)Biogen Inc$10M at Q1 2026
Estimated, from reported holdings
Quarter by quarter
High-conviction buys (new positions at 3% or more of the portfolio) since Q3 2023: 1. Of 0 with six months of history, — beat the S&P 500 from the filing date.
Source: SEC Form 13F-HR 0000905148-26-003712, compared with the Q1 2026 report. 3 option rows are excluded from weights. Tickers map from CUSIP via OpenFIGI. Estimated returns weight each position’s next-quarter total return (Yahoo Finance adjusted closes) by its quarter-end value and assume no trades. Estimated cost averages daily adjusted closes in each quarter the share count rose, from Q3 2023 onward (* = held at the start of our data). Price is the latest close.
Important information
Form 13F data is delayed. Managers have up to 45 days after each calendar quarter to file, so holdings shown may have changed materially since the report date. 13F reports cover long positions in US-listed equities and certain other securities only; they exclude short positions, most non-US holdings, cash, bonds and private investments, and managers may request confidential treatment for some positions. Options rows are listed in filings but are not counted in the holdings and weights shown here.
Estimated holdings returns, estimated cost and high-conviction results are hypothetical calculations from quarter-end holdings and public prices, assuming no trades between reports. They are not the actual returns or costs of any fund or manager and do not reflect fees, trading, leverage, shorts or cash. Biographies are drawn from cited public sources. This page is for information only and is not individualized investment advice or a recommendation to buy or sell any security. Gulfstream Capital and its clients may hold positions in securities shown.